ici 204,219 has been researched along with dinoprostone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chan, SC; Feng, TC; Ho, CK; Su, YC; Tsai, JJ | 1 |
| Aggarwal, S; Johns, DP; Misso, NL; Reid, DW; Thompson, PJ; Walters, EH | 1 |
3 other study(ies) available for ici 204,219 and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Enhanced prostaglandin E2 secretion in sputum from asthmatic patients after zafirlukast therapy.
Topics: Adult; Aged; Anti-Asthmatic Agents; Asthma; Blood Proteins; Dinoprostone; Eosinophil Granule Proteins; Humans; Indoles; Leukotriene Antagonists; Leukotriene E4; Maximal Expiratory Flow Rate; Middle Aged; Phenylcarbamates; Ribonucleases; Sputum; Sulfonamides; Tosyl Compounds | 2001 |
Tolerance and rebound with zafirlukast in patients with persistent asthma.
Topics: Adult; Aged; Asthma; Dinoprostone; Double-Blind Method; Female; Humans; Indoles; Leukotriene Antagonists; Male; Methacholine Chloride; Middle Aged; Nitric Oxide; Peak Expiratory Flow Rate; Phenylcarbamates; Placebos; Receptors, Adrenergic, beta-2; Sulfonamides; Tosyl Compounds | 2008 |